These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Effect of ubiquitin-proteasome pathway on TRAIL inducing apoptosis]. Yang XW Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Feb; 29(1):54-7. PubMed ID: 16137006 [TBL] [Abstract][Full Text] [Related]
4. Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells. Gong B; Almasan A Cancer Res; 2000 Oct; 60(20):5754-60. PubMed ID: 11059770 [TBL] [Abstract][Full Text] [Related]
5. Susceptibility of rheumatoid arthritis synovial fibroblasts to FasL- and TRAIL-induced apoptosis is cell cycle-dependent. Pundt N; Peters MA; Wunrau C; Strietholt S; Fehrmann C; Neugebauer K; Seyfert C; van Valen F; Pap T; Meinecke I Arthritis Res Ther; 2009; 11(1):R16. PubMed ID: 19196465 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY; Yue P; Hong WK; Lotan R Cancer Res; 2000 Dec; 60(24):7149-55. PubMed ID: 11156424 [TBL] [Abstract][Full Text] [Related]
7. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL-induced apoptosis. Evdokiou A; Bouralexis S; Atkins GJ; Chai F; Hay S; Clayer M; Findlay DM Int J Cancer; 2002 Jun; 99(4):491-504. PubMed ID: 11992538 [TBL] [Abstract][Full Text] [Related]
8. Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis. Jüngel A; Baresova V; Ospelt C; Simmen BR; Michel BA; Gay RE; Gay S; Seemayer CA; Neidhart M Ann Rheum Dis; 2006 Jul; 65(7):910-2. PubMed ID: 16284094 [TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin (OPG) acts as an endogenous decoy receptor in tumour necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of fibroblast-like synovial cells. Miyashita T; Kawakami A; Nakashima T; Yamasaki S; Tamai M; Tanaka F; Kamachi M; Ida H; Migita K; Origuchi T; Nakao K; Eguchi K Clin Exp Immunol; 2004 Aug; 137(2):430-6. PubMed ID: 15270863 [TBL] [Abstract][Full Text] [Related]
10. Adenovirus E1A reverses the resistance of normal primary human lung fibroblast cells to TRAIL through DR5 upregulation and caspase 8-dependent pathway. Zhu H; Ling W; Hu B; Su Y; Qiu S; Xiao W; Qi Y Cancer Biol Ther; 2006 Feb; 5(2):180-8. PubMed ID: 16357524 [TBL] [Abstract][Full Text] [Related]
11. Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Park YW; Ji JD; Lee JS; Ryang DW; Yoo DH Scand J Rheumatol; 2003; 32(6):356-63. PubMed ID: 15080267 [TBL] [Abstract][Full Text] [Related]
12. Thyroid carcinoma cells are resistant to FAS-mediated apoptosis but sensitive to tumor necrosis factor-related apoptosis-inducing ligand. Mitsiades N; Poulaki V; Tseleni-Balafouta S; Koutras DA; Stamenkovic I Cancer Res; 2000 Aug; 60(15):4122-9. PubMed ID: 10945619 [TBL] [Abstract][Full Text] [Related]
13. The monoclonal antibody 225 activates caspase-8 and induces apoptosis through a tumor necrosis factor receptor family-independent pathway. Liu B; Fan Z Oncogene; 2001 Jun; 20(28):3726-34. PubMed ID: 11439335 [TBL] [Abstract][Full Text] [Related]
14. Apo2L/TRAIL differentially modulates the apoptotic effects of sulindac and a COX-2 selective non-steroidal anti-inflammatory agent in Bax-deficient cells. He Q; Luo X; Huang Y; Sheikh MS Oncogene; 2002 Sep; 21(39):6032-40. PubMed ID: 12203115 [TBL] [Abstract][Full Text] [Related]
15. Activation of p38 MAPK by damnacanthal mediates apoptosis in SKHep 1 cells through the DR5/TRAIL and TNFR1/TNF-α and p53 pathways. Lin FL; Hsu JL; Chou CH; Wu WJ; Chang CI; Liu HJ Eur J Pharmacol; 2011 Jan; 650(1):120-9. PubMed ID: 20951126 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of neurotrophic factors on tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis of murine adrenal chromaffin cell line tsAM5D. Murata T; Tsuboi M; Hikita K; Kaneda N J Biol Chem; 2006 Aug; 281(32):22503-16. PubMed ID: 16772303 [TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5. Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135 [TBL] [Abstract][Full Text] [Related]
18. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X; Kandasamy K; Srivastava RK Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723 [TBL] [Abstract][Full Text] [Related]
19. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K; Douglas L; Delaney A; Houghton JA Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455 [TBL] [Abstract][Full Text] [Related]
20. Tunicamycin enhances tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human prostate cancer cells. Shiraishi T; Yoshida T; Nakata S; Horinaka M; Wakada M; Mizutani Y; Miki T; Sakai T Cancer Res; 2005 Jul; 65(14):6364-70. PubMed ID: 16024639 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]